ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

KTTA Pasithea Therapeutics Corporation

6.92
0.00 (0.00%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Pasithea Therapeutics Corporation KTTA NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.00% 6.92 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
7.17 7.17 7.17 6.92 6.92
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
29/4/202406:59GLOBEPasithea Therapeutics Announces PAS-004 Abstract Accepted..
24/4/202406:59GLOBEPasithea Therapeutics Announces the First Cohort has..
01/3/202420:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202420:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202420:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202420:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202406:59GLOBEPasithea Therapeutics Announces Opening of Enrollment in the..
18/1/202415:30EDGAR2Form 8-K - Current report
08/1/202406:59GLOBEPasithea Therapeutics Announces Invention of Crystalline..
02/1/202415:47EDGAR2Form 8-K - Current report
02/1/202407:35GLOBEPasithea Therapeutics Announces FDA Acceptance of IND..
28/12/202316:00EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
28/12/202316:00GLOBEPasithea Therapeutics Announces Adjournment of Reconvened..
28/12/202310:30EDGAR2Form 8-K - Current report
19/12/202316:26EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
19/12/202316:21EDGAR2Form 8-K - Current report
19/12/202316:19GLOBEPasithea Therapeutics Announces Results from 2023 Annual..
11/12/202307:01GLOBEPasithea Therapeutics Announces Positive In Vivo Preclinical..
29/11/202316:00EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
29/11/202315:27GLOBEPasithea Therapeutics Announces Adjournment of 2023 Annual..
29/11/202306:59GLOBEPasithea Therapeutics Announces Outcome of Pre-IND Meeting..
13/11/202315:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202306:59GLOBEPasithea Therapeutics Selects PAS-003 Lead Development..
26/10/202316:01EDGAR2Form ARS - Annual Report to Security Holders
26/10/202316:00EDGAR2Form DEF 14A - Other definitive proxy statements
16/10/202316:18EDGAR2Form PRE 14A - Other preliminary proxy statements
13/10/202316:00EDGAR2Form 8-K - Current report
14/9/202308:15EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
14/9/202308:11EDGAR2Form 8-K - Current report
14/9/202307:30GLOBEPasithea Therapeutics Corp. Announces Final Results of..
07/9/202315:14GLOBEPasithea Therapeutics to Participate in H.C. Wainwright 25th..
24/8/202316:00EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
21/8/202316:22EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
14/8/202308:02EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
11/8/202316:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202308:08EDGAR2Form SC TO-I - Tender offer statement by Issuer
01/8/202306:59GLOBEPasithea Therapeutics publishes study in Proceedings of the..
20/7/202308:03EDGAR2Form SC TO-C - Written communication relating to an issuer..
20/7/202307:56EDGAR2Form 8-K - Current report
20/7/202307:43GLOBEPasithea Therapeutics Announces Intention to Commence a..
20/7/202307:40GLOBEPasithea Therapeutics Special Committee Rejects Unsolicited..
20/7/202307:31EDGAR2Form 8-K - Current report
03/7/202316:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
30/6/202308:28GLOBEPasithea Therapeutics Confirms Previous Creation of..
29/6/202313:50GLOBELucy Scientific Discovery Reiterates Its Proposal to Acquire..
29/6/202307:29GLOBEPasithea Therapeutics Announces Completion of GMP..
06/6/202315:30GLOBEPasithea Therapeutics Confirms Receipt of Unsolicited..
05/6/202308:00GLOBELucy Scientific Discovery Announces Proposal to Acquire..
01/6/202306:57GLOBEPasithea Therapeutics Abstract Accepted for Poster..

Su Consulta Reciente

Delayed Upgrade Clock